unknown
Stage
1
Investors
About
Defymed is a medical device company developing innovative implantable devices for the treatment of Type 1 diabetes. Their Mailpan® technology protects insulin-producing cells from immune system destruction.
Explore Defymed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.